Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study status on the page is updated to Completed and results are posted, including 6-month tumor response data (PR/SD/PD) and survival outcomes (DFS and OS). A PDF of the Study Protocol and Statistical Analysis Plan was added to the Study Documents.SummaryDifference3%

- Check72 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No changes to the trial details or visible content.SummaryDifference0.1%

- Check79 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now displays 'Results Submitted' and removes the 'No Results Posted' message.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.